Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Distributed through LillyDirect 's self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand
Centers for Medicare and Medicaid Services (CMS) announced that Medicare would cover semaglutide/Wegovy if prescribed for its cardiac benefits
Severe or progressive muscle weakness that interferes with daily activitiessuch as difficulty climbing stairs, rising from a chair, or lifting objectsrequires medical assessment
Full-service restaurants could actually benefit from GLP-1: Spending has increased, suggest a shift from convenience dining toward more experiential or quality-focused dining occasions
US$ 27.70
US$ 23.35
US$ 28.78
US$ 22.29
US$ 21.80
US$ 24.84
US$ 24.42
